334 GENES FOUNDi
Show / hide columns XML | RDF | TSV | « prev | Page of 7 | next »
Genei Gene descriptioni x Protein classi x Tissue Cell Pathology Subcellular locationi x Prognostic p-valuei x RNA tissue categoryi x
NPHS2NPHS2, podocinDisease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Tissue enriched
NPR3Natriuretic peptide receptor 3Predicted intracellular proteins
Predicted membrane proteins
CytosolRenal cancer: 5.43e-6
Tissue enriched
NXPH2Neurexophilin 2Predicted secreted proteins
Group enriched
OGDHLOxoglutarate dehydrogenase-likeCitric acid cycle related proteins
Predicted intracellular proteins
Nucleus
Nucleoli fibrillar center
Cytosol
Renal cancer: 1.21e-14
Tissue enhanced
OR2T10Olfactory receptor family 2 subfamily T member 10G-protein coupled receptors
Predicted membrane proteins
Tissue enriched
OTOGLOtogelin likeDisease related genes
Predicted intracellular proteins
Predicted secreted proteins
CytosolTissue enriched
PAHPhenylalanine hydroxylaseDisease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Endoplasmic reticulum
Vesicles
Liver cancer: 4.30e-4
Tissue enhanced
PANK1Pantothenate kinase 1Enzymes
Predicted intracellular proteins
Renal cancer: 1.55e-10
Liver cancer: 1.50e-4
Tissue enhanced
PAQR5Progestin and adipoQ receptor family member 5Predicted membrane proteins
VesiclesRenal cancer: 1.47e-14
Pancreatic cancer: 2.15e-5
Tissue enhanced
PAX2Paired box 2Disease related genes
Predicted intracellular proteins
Predicted secreted proteins
Transcription factors
Nucleoli
Golgi apparatus
Endometrial cancer: 4.56e-4
Group enriched
PCK1Phosphoenolpyruvate carboxykinase 1Citric acid cycle related proteins
Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Renal cancer: 1.47e-5
Tissue enhanced
PCK2Phosphoenolpyruvate carboxykinase 2, mitochondrialCitric acid cycle related proteins
Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
MitochondriaLiver cancer: 2.81e-4
Group enriched
PCSK1NProprotein convertase subtilisin/kexin type 1 inhibitorPredicted secreted proteins
VesiclesEndometrial cancer: 1.15e-4
Renal cancer: 1.36e-4
Tissue enhanced
PDZD3PDZ domain containing 3Predicted intracellular proteins
Tissue enhanced
PDZK1PDZ domain containing 1Predicted intracellular proteins
Nucleoplasm
Vesicles
Cytosol
Renal cancer: 2.54e-7
Tissue enhanced
PFN3Profilin 3Predicted intracellular proteins
Group enriched
PIPOXPipecolic acid and sarcosine oxidaseEnzymes
Plasma proteins
Predicted intracellular proteins
Pancreatic cancer: 1.49e-4
Group enriched
PKLRPyruvate kinase, liver and RBCDisease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Endoplasmic reticulum
Golgi apparatus
Tissue enhanced
PLA2G12BPhospholipase A2 group XIIBPlasma proteins
Predicted secreted proteins
RAS pathway related proteins
VesiclesGroup enriched
PM20D1Peptidase M20 domain containing 1Enzymes
Predicted secreted proteins
Tissue enhanced
POU3F3POU class 3 homeobox 3Predicted intracellular proteins
Transcription factors
NucleusEndometrial cancer: 4.26e-5
Group enriched
PRODH2Proline dehydrogenase 2Enzymes
Predicted intracellular proteins
Nucleoplasm
Cytosol
Group enriched
PROZProtein Z, vitamin K dependent plasma glycoproteinCandidate cardiovascular disease genes
Enzymes
Plasma proteins
Predicted secreted proteins
Liver cancer: 3.46e-4
Group enriched
PRR35Proline rich 35Predicted intracellular proteins
Tissue enhanced
PTGER1Prostaglandin E receptor 1FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Tissue enhanced
PTGER3Prostaglandin E receptor 3FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Renal cancer: 3.50e-4
Group enriched
PTH1RParathyroid hormone 1 receptorDisease related genes
G-protein coupled receptors
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Renal cancer: 6.79e-6
Tissue enhanced
RALYLRALY RNA binding protein-likePredicted intracellular proteins
NucleoplasmTissue enhanced
RANBP3LRAN binding protein 3 likePredicted intracellular proteins
NucleoplasmTissue enhanced
RBP5Retinol binding protein 5Plasma proteins
Predicted intracellular proteins
Golgi apparatus
Vesicles
Urothelial cancer: 3.68e-4
Lung cancer: 8.37e-4
Tissue enhanced
RDH8Retinol dehydrogenase 8 (all-trans)Predicted intracellular proteins
Predicted secreted proteins
Group enriched
RENReninCandidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted secreted proteins
Renal cancer: 6.45e-5
Tissue enhanced
RHBGRh family B glycoprotein (gene/pseudogene)Predicted membrane proteins
Transporters
NucleoplasmUrothelial cancer: 8.06e-4
Tissue enhanced
RIDAReactive intermediate imine deaminase A homologPlasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Liver cancer: 9.61e-6
Group enriched
RIPPLY1Ripply transcriptional repressor 1Predicted secreted proteins
Tissue enhanced
RNF152Ring finger protein 152Enzymes
Predicted intracellular proteins
Predicted membrane proteins
Renal cancer: 1.13e-8
Stomach cancer: 2.85e-5
Tissue enriched
RNF212BRing finger protein 212BPredicted intracellular proteins
Group enriched
RP11-606E8.2Predicted intracellular proteins
Nucleoplasm
Vesicles
Tissue enhanced
RP4-583P15.14Predicted intracellular proteins
Tissue enhanced
SCNN1GSodium channel epithelial 1 gamma subunitDisease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Nucleoplasm
Plasma membrane
Renal cancer: 3.20e-7
Tissue enhanced
SFXN2Sideroflexin 2Predicted intracellular proteins
Predicted membrane proteins
MitochondriaRenal cancer: 2.28e-5
Cervical cancer: 2.28e-4
Urothelial cancer: 6.52e-4
Liver cancer: 9.95e-4
Tissue enhanced
SHISA3Shisa family member 3Predicted membrane proteins
Lipid droplets
Cytosol
Tissue enhanced
SIM1Single-minded family bHLH transcription factor 1Plasma proteins
Predicted intracellular proteins
Transcription factors
Nuclear specklesRenal cancer: 5.32e-7
Tissue enhanced
SIM2Single-minded family bHLH transcription factor 2Predicted intracellular proteins
Transcription factors
Nucleoplasm
Nuclear bodies
Endometrial cancer: 2.10e-4
Urothelial cancer: 2.88e-4
Tissue enhanced
SLC10A2Solute carrier family 10 member 2Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Renal cancer: 5.78e-5
Group enriched
SLC12A1Solute carrier family 12 member 1Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Nucleus
Vesicles
Tissue enriched
SLC12A3Solute carrier family 12 member 3Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Tissue enriched
SLC13A1Solute carrier family 13 member 1Predicted membrane proteins
Transporters
Renal cancer: 8.95e-5
Tissue enriched
SLC13A3Solute carrier family 13 member 3Predicted membrane proteins
Transporters
Plasma membraneTissue enriched
SLC14A2Solute carrier family 14 member 2Plasma proteins
Predicted membrane proteins
Transporters
Tissue enhanced
« prev | Page of 7 | next »